284 related articles for article (PubMed ID: 30940048)
1. Clinico-epidemiologic characteristics and patterns of care in Kaposi's sarcoma: Data from a single-institution series.
Hwang A; Iskandar AS; Kerr WT; Farrell S; Plaxe SC; Dasanu CA
J Oncol Pharm Pract; 2019 Oct; 25(7):1719-1721. PubMed ID: 30940048
[TBL] [Abstract][Full Text] [Related]
2. [AIDS-associated Kaposi's sarcoma: 22 cases].
Dhrif AS; Kilani B; Ammari L; Kanoun F; Tiouri H; Ben Chaaben T
Tunis Med; 2007 Jun; 85(6):494-9. PubMed ID: 17644904
[TBL] [Abstract][Full Text] [Related]
3. Immunosenescence is associated with presence of Kaposi's sarcoma in antiretroviral treated HIV infection.
Unemori P; Leslie KS; Hunt PW; Sinclair E; Epling L; Mitsuyasu R; Effros RB; Dock J; Dollard SG; Deeks SG; Martin JN; Maurer TA
AIDS; 2013 Jul; 27(11):1735-42. PubMed ID: 23435301
[TBL] [Abstract][Full Text] [Related]
4. Kaposi's sarcoma in HIV infection: impact on opportunistic infections and survival.
Brodt HR; Kamps BS; Helm EB; Schöfer H; Mitrou P
AIDS; 1998 Aug; 12(12):1475-81. PubMed ID: 9727568
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology of Kaposi's sarcoma-associated herpesvirus in HIV-1-infected US persons in the era of combination antiretroviral therapy.
Labo N; Miley W; Benson CA; Campbell TB; Whitby D
AIDS; 2015 Jun; 29(10):1217-25. PubMed ID: 26035321
[TBL] [Abstract][Full Text] [Related]
6. AIDS-associated Kaposi's sarcoma is linked to advanced disease and high mortality in a primary care HIV programme in South Africa.
Chu KM; Mahlangeni G; Swannet S; Ford NP; Boulle A; Van Cutsem G
J Int AIDS Soc; 2010 Jul; 13():23. PubMed ID: 20615222
[TBL] [Abstract][Full Text] [Related]
7. Interferon lambda 3/4 polymorphisms are associated with AIDS-related Kaposi's sarcoma.
Bibert S; Wójtowicz A; Taffé P; Tarr PE; Bernasconi E; Furrer H; Günthard HF; Hoffmann M; Kaiser L; Osthoff M; Fellay J; Cavassini M; Bochud PY;
AIDS; 2018 Nov; 32(18):2759-2765. PubMed ID: 30234607
[TBL] [Abstract][Full Text] [Related]
8. Changing patterns of Kaposi's sarcoma in Danish acquired immunodeficiency syndrome patients with complete follow-up. The Danish Study Group for HIV Infection (DASHI).
Lundgren JD; Melbye M; Pedersen C; Rosenberg PS; Gerstoft J
Am J Epidemiol; 1995 Apr; 141(7):652-8. PubMed ID: 7702040
[TBL] [Abstract][Full Text] [Related]
9. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma.
Renwick N; Halaby T; Weverling GJ; Dukers NH; Simpson GR; Coutinho RA; Lange JM; Schulz TF; Goudsmit J
AIDS; 1998 Dec; 12(18):2481-8. PubMed ID: 9875587
[TBL] [Abstract][Full Text] [Related]
10. Mortality disparities among patients with HIV-associated Kaposi's sarcoma in the southern United States.
Knights SM; Lazarte SM; Kainthla R; Chiao EY; Nijhawan AE
AIDS; 2022 Apr; 36(5):721-728. PubMed ID: 34930860
[TBL] [Abstract][Full Text] [Related]
11. [Diagnosis and treatment of HIV-related Kaposi's sarcoma].
Reyners AK; Sprenger HG; Suurmeijer AJ; van der Graaf WT
Ned Tijdschr Geneeskd; 2006 Mar; 150(11):589-93. PubMed ID: 16610494
[TBL] [Abstract][Full Text] [Related]
12. [Kaposi's sarcoma during HIV infection in Morocco (apropos of 50 cases)].
Chakib A; Hliwa W; Marih L; Himmich H
Bull Soc Pathol Exot; 2003 May; 96(2):86-9. PubMed ID: 12836521
[TBL] [Abstract][Full Text] [Related]
13. A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma.
Nasti G; Errante D; Santarossa S; Vaccher E; Tirelli U
Drug Saf; 1999 May; 20(5):403-25. PubMed ID: 10348092
[TBL] [Abstract][Full Text] [Related]
14. Changes in the pattern of Kaposi's sarcoma at Ocean Road Cancer Institute in Tanzania (2006-2011).
Koski L; Ngoma T; Mwaiselage J; Le L; Soliman AS
Int J STD AIDS; 2015 Jun; 26(7):470-8. PubMed ID: 25080290
[TBL] [Abstract][Full Text] [Related]
15. Brain localization of Kaposi's sarcoma in a patient treated by combination antiretroviral therapy.
Baldini F; Baiocchini A; Schininà V; Agrati C; Giancola ML; Alba L; Grisetti S; Del Nonno F; Capobianchi MR; Antinori A
BMC Infect Dis; 2013 Dec; 13():600. PubMed ID: 24359263
[TBL] [Abstract][Full Text] [Related]
16. Kaposi's sarcoma and central nervous system disease: a real association or an artifact of the control group? Terry Beirn Community Programs for Clinical Research on AIDS.
Eberly LE; Ohman PA; Neaton JD; Price RW; Abrams DI
AIDS; 2000 May; 14(8):995-1000. PubMed ID: 10853981
[TBL] [Abstract][Full Text] [Related]
17. Epidemiology of Kaposi's sarcoma.
Beral V
Cancer Surv; 1991; 10():5-22. PubMed ID: 1821323
[TBL] [Abstract][Full Text] [Related]
18. Anti-herpesvirus treatment and risk of Kaposi's sarcoma in HIV infection. Royal Free/Chelsea and Westminster Hospitals Collaborative Group.
Mocroft A; Youle M; Gazzard B; Morcinek J; Halai R; Phillips AN
AIDS; 1996 Sep; 10(10):1101-5. PubMed ID: 8874626
[TBL] [Abstract][Full Text] [Related]
19. Kaposi's-sarcoma-associated herpesvirus is detected in peripheral blood mononuclear cells of HIV-infected homosexuals more often than in heterosexuals.
Rizzieri DA; Liu J; Miralles D; Traweek ST
Cancer J Sci Am; 1997; 3(3):153-6. PubMed ID: 9161780
[TBL] [Abstract][Full Text] [Related]
20. Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma.
Bower M; Fox P; Fife K; Gill J; Nelson M; Gazzard B
AIDS; 1999 Oct; 13(15):2105-11. PubMed ID: 10546864
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
